CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study

被引：9
|
作者：
Niu, Jiahua [1 ,2 ]
Qiu, Huiying [1 ,2 ]
Xiang, Fang [3 ]
Zhu, Lin [3 ]
Yang, Jun [1 ,2 ]
Huang, Chongmei [1 ,2 ]
Zhou, Kun [1 ,2 ]
Tong, Yin [1 ,2 ]
Cai, Yu [1 ,2 ]
Dong, Baoxia [1 ,2 ]
Lu, Yuan [3 ]
Sun, Xuedong [3 ]
Wan, Liping [1 ,2 ]
Ding, Xueying [2 ]
Wang, Haopeng [4 ]
Song, Xianmin [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Dept Hematol, Shanghai, Peoples R China
[2] Shanghai Sci & Technol Comm STCSM, Engn Technol Res Ctr Cell Therapy & Clin Translat, Shanghai, Peoples R China
[3] Hrain Biotechnol, Shanghai, Peoples R China
[4] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China
来源：
BLOOD CANCER JOURNAL | 2023年 / 13卷 / 01期
基金：
国家重点研发计划;
关键词：
THERAPY; CD19;
D O I：
10.1038/s41408-023-00813-x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Remission of acute myeloid leukemia with t(8;21) following CD19 CAR T-cells
    Danylesko, Ivetta
    Jacoby, Elad
    Yerushalmi, Ronit
    Shem-Tov, Noga
    Besser, Michal J.
    Vernitsky, Helly
    Marcu-Malina, Victoria
    Shimoni, Avichai
    Avigdor, Abraham
    Nagler, Arnon
    LEUKEMIA, 2020, 34 (07) : 1939 - 1942
  • [22] Clinical outcomes and safety of CAR-T cells in treatment of T-Cell acute lymphoblastic leukemia/lymphoma
    Ma, Jin-Feng
    Yan, Chun-Long
    Jia, Xu
    Zhu, Hong-Jia
    Yan, Jia-Wei
    Liu, Mei-Jing
    Zhang, Dai-Yi
    Liu, Shen-Hao
    Xu, Nan
    Zhang, Hai-Guo
    Ye, Ling
    Yu, Lei
    Wu, De-Pei
    Gong, Wen-Jie
    Dai, Hai-Ping
    Xue, Sheng-Li
    ANNALS OF HEMATOLOGY, 2025, 104 (01) : 57 - 63
  • [23] Evidence of long-lasting anti-CD19 activity of engrafted CD19 chimeric antigen receptor-modified T cells in a phase I study targeting pediatrics with acute lymphoblastic leukemia
    Ma, Futian
    Ho, Jin-Yuan
    Du, Huan
    Xuan, Fan
    Wu, Xiaoli
    Wang, Qinglong
    Wang, Lin
    Liu, Ying
    Ba, Min
    Wang, Yizhuo
    Luo, Jianmin
    Li, Jianqiang
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (05) : 601 - 608
  • [24] Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia
    Liu, Shuangyou
    Deng, Biping
    Yin, Zhichao
    Pan, Jing
    Lin, Yuehui
    Ling, Zhuojun
    Wu, Tong
    Chen, Dong
    Chang, Alex H.
    Gao, Zhiyong
    Song, Yanzhi
    Zhao, Yongqiang
    Tong, Chunrong
    BLOOD CANCER JOURNAL, 2020, 10 (02)
  • [25] Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia
    Zhang, Cheng
    He, Jiaping
    Liu, Li
    Wang, Jishi
    Wang, Sanbin
    Liu, Ligen
    Ge, Jian
    Gao, Lei
    Gao, Li
    Kong, Peiyan
    Liu, Yao
    Liu, Jia
    Han, Yu
    Zhang, Yongliang
    Sun, Zhe
    Ye, Xun
    Yin, Wenjie
    Sersch, Martina
    Shen, Lianjun
    Cao, Wei William
    Zhang, Xi
    BLOOD CANCER JOURNAL, 2022, 12 (06)
  • [26] CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual disease
    Lu, Wenyi
    Wei, Yunxiong
    Cao, Yaqing
    Xiao, Xia
    Li, Qing
    Lyu, Hairong
    Jiang, Yili
    Zhang, Huan
    Li, Xin
    Jiang, Yanyu
    Meng, Juanxia
    Yuan, Ting
    Zhu, Haibo
    He, Xiaoyuan
    Jin, Xin
    Sun, Rui
    Sui, Tao
    Liu, Kaiqi
    Zhao, Mingfeng
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (12) : 3501 - 3511
  • [27] CD19-Specific CAR-T Cell Treatment of 115 Children and Young Adults with Acute B Lymphoblastic Leukemia: Long-term Follow-up
    Wang, Yu
    Xue, Yu-juan
    Zuo, Ying-xi
    Jia, Yue-ping
    Lu, Ai-dong
    Zeng, Hui-min
    Zhang, Le-ping
    CANCER RESEARCH AND TREATMENT, 2024, 56 (03): : 945 - 955
  • [28] Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia
    Cao, Jiang
    Wang, Gang
    Cheng, Hai
    Wei, Chen
    Qi, Kunming
    Sang, Wei
    Li Zhenyu
    Shi, Ming
    Li, Huizhong
    Qiao, Jianlin
    Pan, Bin
    Zhao, Jing
    Wu, Qingyun
    Zeng, Lingyu
    Niu, Mingshan
    Jing, Guangjun
    Zheng, Junnian
    Xu, Kailin
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (07) : 851 - 858
  • [29] CAR-T cells and allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia
    Liu, Jun
    Zhang, Xi
    Zhong, Jiang F.
    Zhang, Cheng
    IMMUNOTHERAPY, 2017, 9 (13) : 1115 - 1125
  • [30] Prediction of severe CRS and determination of biomarkers in B cell-acute lymphoblastic leukemia treated with CAR-T cells
    Wei, Zhenyu
    Xu, Jiayu
    Zhao, Chengkui
    Zhang, Min
    Xu, Nan
    Kang, Liqing
    Lou, Xiaoyan
    Yu, Lei
    Feng, Weixing
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345